The MIT Health and Life Sciences Collaborative (MIT HEALS) has announced the establishment of the Fairbairn Menstruation Science Fund, supporting a bold, high-impact initiative designed to revolutionize women’s health research.
Established through a gift from Emily and Malcolm Fairbairn, the fund will advance groundbreaking research on the function of the human uterus and its impact on sex-based differences in human immunology that contribute to gynecological disorders such as endometriosis, as well as other chronic systemic inflammatory diseases that disproportionately affect women, such as Lyme disease and lupus. The Fairbairns, based in the San Francisco Bay Area, have committed $10 million, with a call to action for an additional $10 million in matching funds.
“I’m deeply grateful to Emily and Malcolm Fairbairn for their visionary support of menstruation science at MIT. For too long, this area of research has lacked broad scientific investment and visibility, despite its profound impact on the health and lives of over half the population,” says Anantha P.
